上颌Le Fort Ⅰ型截骨术是正颌外科中矫治上颌骨畸形最常采用术式之一。但是,上颌骨的移动、肌肉的剥离会影响周围软组织的形态,其中鼻形态的改变越来越受到重视。已有研究报道,正颌手术后鼻形态的不利改变是降低患者手术满意度的主要...上颌Le Fort Ⅰ型截骨术是正颌外科中矫治上颌骨畸形最常采用术式之一。但是,上颌骨的移动、肌肉的剥离会影响周围软组织的形态,其中鼻形态的改变越来越受到重视。已有研究报道,正颌手术后鼻形态的不利改变是降低患者手术满意度的主要原因之一。明确上颌Le Fort Ⅰ型截骨术对鼻形态的影响能够帮助医生更准确地预测术后鼻形态的变化,从而优化手术设计、提高医患沟通效率。本文将对上颌Le Fort Ⅰ型截骨术后鼻部形态变化的研究进展作一综述,旨在为临床实践提供相应的参考。展开更多
上颌窦炎是Le Fort Ⅰ型截骨术后常见的并发症,对正颌术后的骨质愈合等非常不利。明确Le Fort Ⅰ型截骨术后上颌窦炎发生的相关因素,针对性采取预防措施,早期发现与及时治疗,对于降低上颌窦炎的发生率,加快患者术后康复,以及提升患者术...上颌窦炎是Le Fort Ⅰ型截骨术后常见的并发症,对正颌术后的骨质愈合等非常不利。明确Le Fort Ⅰ型截骨术后上颌窦炎发生的相关因素,针对性采取预防措施,早期发现与及时治疗,对于降低上颌窦炎的发生率,加快患者术后康复,以及提升患者术后生活质量具有重要意义。本文就上颌骨Le Fort Ⅰ型截骨术后并发上颌窦炎的影响、病因、诊断、治疗和预防等进行总结,为正颌外科相关医护人员早期诊治上颌窦炎提供参考。展开更多
目的:探讨改良鼻旁植骨是否能减少Le Fort 1型截骨下降手术术后上颌骨垂直向的复发。方法:选择双颌手术中上颌骨下降幅度>3 mm的患者30例,分为改良鼻旁植骨组和非改良鼻旁植骨组。利用术前(T0)、术后3天(T1)和术后6个月(T2)的颌面CT...目的:探讨改良鼻旁植骨是否能减少Le Fort 1型截骨下降手术术后上颌骨垂直向的复发。方法:选择双颌手术中上颌骨下降幅度>3 mm的患者30例,分为改良鼻旁植骨组和非改良鼻旁植骨组。利用术前(T0)、术后3天(T1)和术后6个月(T2)的颌面CT数据对上颌骨位置进行三维测量;同时利用T1与T2的CT数据计算植骨块厚度的变化。采用SPSS 22.0软件包对数据进行统计学分析。结果:术后6个月,在垂直方向上,改良鼻旁植骨组上切牙点复发量为(0.54±0.35)mm,非改良鼻旁植骨组上切牙点复发量为(1.18±0.76)mm(P=0.3997)。2组在前后、水平方向的复发率无显著差异。改良鼻旁植骨组的植骨块厚度降低(11.75±6.25)%,非改良鼻旁植骨组的植骨块厚度降低(33.77±11.56)%(P<0.0001)。结果:改良鼻旁植骨可有效减少植骨块吸收,以及术后上颌骨垂直向复发。展开更多
BACKGROUND Liver cancer is among the top five most common cancers globally. Lipid-lowering drugs such as statins can lower the risk of liver cancer, but may also cause liver damage. LipoCol Forte capsules(LFC), a red ...BACKGROUND Liver cancer is among the top five most common cancers globally. Lipid-lowering drugs such as statins can lower the risk of liver cancer, but may also cause liver damage. LipoCol Forte capsules(LFC), a red yeast rice product, have demonstrated significant antihypercholesterolemic effects and a good safety profile in clinical studies.AIM To evaluate whether LFC lowers the risk of liver cancer in adults in this propensity score-matched, nationwide, population-based cohort study.METHODS We used data from Taiwan’s National Health Insurance Research Database, which includes electronic medical records for up to 99.99% of Taiwan’s population. LFC users and LFC non-users were matched 1:1 by propensity scores between January 2010 and December 2017. All had followup data for at least 1 year. Statistical analyses compared demographic distributions including sex, age, comorbidities, and prescribed medications. Cox regression analyses estimated adjusted hazard ratios(aHRs) after adjusting for potential confounders.RESULTS We enrolled 33231 LFC users and 33231 non-LFC users(controls). No significant differences between the study cohorts were identified regarding comorbidities and medications [standardized mean difference(SMD) < 0.05]. At follow-up, the overall incidence of liver cancer was significantly lower in the LFC cohort compared with controls [aHR 0.91;95% confidence interval(CI): 0.86-0.95;P < 0.001]. The risk of liver cancer was significantly reduced in both females(aHR 0.87;95%CI: 0.8-0.94;P < 0.001) and males(aHR 0.93;95%CI: 0.87-0.98;P < 0.01) in the LFC cohort compared with their counterparts in the non-LFC cohort. The antitumor protective effects applied to patients with comorbidities(including hypertension, ischemic stroke, diabetes mellitus, hyperlipidemia, hepatitis B infection and hepatitis C infection). Those using LFC for more than 84 drug days had a 0.64-fold lower risk of liver cancer compared with controls(P < 0.001). Compared with controls, the risk of developing liver cancer in the LFC cohort progressively decreased over time;the lowest incidence of liver cancer occurred in LFC users followed-up for more than 6 years(27.44 vs 31.49 per 1,000 person-years;aHR 0.75;95%CI: 0.68-0.82;P < 0.001).CONCLUSION This retrospective cohort study indicates that LFC has a significantly protective effect on lowering the risk of liver cancer, in a dose-dependent and time-dependent manner.展开更多
目的 探讨联合应用高位Le Fort Ⅰ型截骨同期牙槽嵴裂植骨矫治唇腭裂术后面中部畸形的可行性。方法2002年1月～2005年1月，共收治10例唇腭裂术后面中部畸形患者，男4例，女6例。年龄16～32岁。单侧唇腭裂8例，双侧2例。影像学检查均有...目的 探讨联合应用高位Le Fort Ⅰ型截骨同期牙槽嵴裂植骨矫治唇腭裂术后面中部畸形的可行性。方法2002年1月～2005年1月，共收治10例唇腭裂术后面中部畸形患者，男4例，女6例。年龄16～32岁。单侧唇腭裂8例，双侧2例。影像学检查均有继发面中部畸形的主要表现。均采用高位Le Fort Ⅰ型截骨和牙槽嵴裂自体髂骨游离移植一期手术矫正。高位Le Fort Ⅰ型截骨的截骨线在上颌骨前壁比常规Le Fort Ⅰ型截骨线高，最高可达眶下孔下5mm左右，水平截开至颧牙槽嵴处再弧形转向下后方。结果术后伤口均I期愈合。复查头部X线片，所有患者上颌骨位置均得到明显改善。随访6～24个月，牙弓外形良好，X线片示无明显骨质吸收，植骨区密度与周围接近。10例均获得满意面容，其中9例获得良好的牙骀关系。结论高位Le Fort Ⅰ型截骨术不仅可前移上颌骨，还可前移部分眶下区及整个鼻旁区和鼻底，更明显地改善畸形。同期行牙槽嵴裂自体髂骨游离移植，可减少手术次数、降低费用、获得理想效果，是矫治唇腭裂术后面中部继发畸形的一种有效方法。展开更多
目的:采用多片段Le Fort I型截骨术矫治严重牙颌面畸形,并为克服术后骨段固位不良之缺点自制一种腭侧固定夹板。方法:以该手术方法联合双侧下颌升支矢状劈开术（BSSRO）矫治上颌宽度不足伴上下颌其它严重畸形的患者19例。采用单纯多片...目的:采用多片段Le Fort I型截骨术矫治严重牙颌面畸形,并为克服术后骨段固位不良之缺点自制一种腭侧固定夹板。方法:以该手术方法联合双侧下颌升支矢状劈开术（BSSRO）矫治上颌宽度不足伴上下颌其它严重畸形的患者19例。采用单纯多片段Le FortI型截骨6例,联合BSSRO13例。19例中上颌两片段Le FortI型截骨12例,3片段7例。结果:术后随访16例,平均22.6m,66间距离平均扩宽7.3mm,33间平均扩宽3.9mm。无严重并发症及明显复发,咬合关系满意。结论:应用良好的腭侧固定夹板,采用多片段 Le FortI截骨联合BSSRO可一次满意矫治严重双颌畸形。展开更多
目的本研究通过主观及客观性评估方法,对上颌骨Le Fort Ⅰ型截骨上颌骨向不同方向移动后鼻腔通气功能的变化进行评估。方法将30例需要接受正颌手术治疗的患者分为2组,前移组1 3例,采用上颌骨Le Fort I型截骨前移术;非前移组:1 7例,采用...目的本研究通过主观及客观性评估方法,对上颌骨Le Fort Ⅰ型截骨上颌骨向不同方向移动后鼻腔通气功能的变化进行评估。方法将30例需要接受正颌手术治疗的患者分为2组,前移组1 3例,采用上颌骨Le Fort I型截骨前移术;非前移组:1 7例,采用上颌骨Le Fort Ⅰ型截骨上抬、后退或下降术。术前、术后3个月及术后6个月分别对研究对象进行前鼻镜及鼻声反射检查。所有研究对象术前及术后6个月均完成NOSE量表的主观性评估,采用SPSS对术前及术后的结果进行统计学分析。结果鼻声反射检测结果显示两组患者的鼻腔阻力、鼻腔容积及鼻腔最小截面积3项指标在术后3个月及6个月时均较术前有所改善,但是前后差异没有统计学意义。NOSE量表的主观性评估结果显示,两研究组于术后6个月时的评估分值即主观症状改善较术前下降,然而仅非前移组术前术后差异有统计学意义。结论上颌骨Le Fort Ⅰ型单块截骨上颌骨向不同方向移动无论从客观上还是主观上都不会对患者的鼻腔通气功能产生不良影响。同时利用客观性(鼻声反射)及主观性(NOSE量表)检测手段可以有效地对鼻腔结构及功能进行评估。展开更多
文摘上颌Le Fort Ⅰ型截骨术是正颌外科中矫治上颌骨畸形最常采用术式之一。但是,上颌骨的移动、肌肉的剥离会影响周围软组织的形态,其中鼻形态的改变越来越受到重视。已有研究报道,正颌手术后鼻形态的不利改变是降低患者手术满意度的主要原因之一。明确上颌Le Fort Ⅰ型截骨术对鼻形态的影响能够帮助医生更准确地预测术后鼻形态的变化,从而优化手术设计、提高医患沟通效率。本文将对上颌Le Fort Ⅰ型截骨术后鼻部形态变化的研究进展作一综述,旨在为临床实践提供相应的参考。
文摘上颌窦炎是Le Fort Ⅰ型截骨术后常见的并发症,对正颌术后的骨质愈合等非常不利。明确Le Fort Ⅰ型截骨术后上颌窦炎发生的相关因素,针对性采取预防措施,早期发现与及时治疗,对于降低上颌窦炎的发生率,加快患者术后康复,以及提升患者术后生活质量具有重要意义。本文就上颌骨Le Fort Ⅰ型截骨术后并发上颌窦炎的影响、病因、诊断、治疗和预防等进行总结,为正颌外科相关医护人员早期诊治上颌窦炎提供参考。
文摘目的:探讨改良鼻旁植骨是否能减少Le Fort 1型截骨下降手术术后上颌骨垂直向的复发。方法:选择双颌手术中上颌骨下降幅度>3 mm的患者30例,分为改良鼻旁植骨组和非改良鼻旁植骨组。利用术前(T0)、术后3天(T1)和术后6个月(T2)的颌面CT数据对上颌骨位置进行三维测量;同时利用T1与T2的CT数据计算植骨块厚度的变化。采用SPSS 22.0软件包对数据进行统计学分析。结果:术后6个月,在垂直方向上,改良鼻旁植骨组上切牙点复发量为(0.54±0.35)mm,非改良鼻旁植骨组上切牙点复发量为(1.18±0.76)mm(P=0.3997)。2组在前后、水平方向的复发率无显著差异。改良鼻旁植骨组的植骨块厚度降低(11.75±6.25)%,非改良鼻旁植骨组的植骨块厚度降低(33.77±11.56)%(P<0.0001)。结果:改良鼻旁植骨可有效减少植骨块吸收,以及术后上颌骨垂直向复发。
基金Supported by the Ministry of Science and Technology of Taiwan,No. NSTC111-2320-B-039-025China Medical University Hospital,No. DMR-111-013 and No. DMR-111-195
文摘BACKGROUND Liver cancer is among the top five most common cancers globally. Lipid-lowering drugs such as statins can lower the risk of liver cancer, but may also cause liver damage. LipoCol Forte capsules(LFC), a red yeast rice product, have demonstrated significant antihypercholesterolemic effects and a good safety profile in clinical studies.AIM To evaluate whether LFC lowers the risk of liver cancer in adults in this propensity score-matched, nationwide, population-based cohort study.METHODS We used data from Taiwan’s National Health Insurance Research Database, which includes electronic medical records for up to 99.99% of Taiwan’s population. LFC users and LFC non-users were matched 1:1 by propensity scores between January 2010 and December 2017. All had followup data for at least 1 year. Statistical analyses compared demographic distributions including sex, age, comorbidities, and prescribed medications. Cox regression analyses estimated adjusted hazard ratios(aHRs) after adjusting for potential confounders.RESULTS We enrolled 33231 LFC users and 33231 non-LFC users(controls). No significant differences between the study cohorts were identified regarding comorbidities and medications [standardized mean difference(SMD) < 0.05]. At follow-up, the overall incidence of liver cancer was significantly lower in the LFC cohort compared with controls [aHR 0.91;95% confidence interval(CI): 0.86-0.95;P < 0.001]. The risk of liver cancer was significantly reduced in both females(aHR 0.87;95%CI: 0.8-0.94;P < 0.001) and males(aHR 0.93;95%CI: 0.87-0.98;P < 0.01) in the LFC cohort compared with their counterparts in the non-LFC cohort. The antitumor protective effects applied to patients with comorbidities(including hypertension, ischemic stroke, diabetes mellitus, hyperlipidemia, hepatitis B infection and hepatitis C infection). Those using LFC for more than 84 drug days had a 0.64-fold lower risk of liver cancer compared with controls(P < 0.001). Compared with controls, the risk of developing liver cancer in the LFC cohort progressively decreased over time;the lowest incidence of liver cancer occurred in LFC users followed-up for more than 6 years(27.44 vs 31.49 per 1,000 person-years;aHR 0.75;95%CI: 0.68-0.82;P < 0.001).CONCLUSION This retrospective cohort study indicates that LFC has a significantly protective effect on lowering the risk of liver cancer, in a dose-dependent and time-dependent manner.
文摘目的 探讨联合应用高位Le Fort Ⅰ型截骨同期牙槽嵴裂植骨矫治唇腭裂术后面中部畸形的可行性。方法2002年1月～2005年1月，共收治10例唇腭裂术后面中部畸形患者，男4例，女6例。年龄16～32岁。单侧唇腭裂8例，双侧2例。影像学检查均有继发面中部畸形的主要表现。均采用高位Le Fort Ⅰ型截骨和牙槽嵴裂自体髂骨游离移植一期手术矫正。高位Le Fort Ⅰ型截骨的截骨线在上颌骨前壁比常规Le Fort Ⅰ型截骨线高，最高可达眶下孔下5mm左右，水平截开至颧牙槽嵴处再弧形转向下后方。结果术后伤口均I期愈合。复查头部X线片，所有患者上颌骨位置均得到明显改善。随访6～24个月，牙弓外形良好，X线片示无明显骨质吸收，植骨区密度与周围接近。10例均获得满意面容，其中9例获得良好的牙骀关系。结论高位Le Fort Ⅰ型截骨术不仅可前移上颌骨，还可前移部分眶下区及整个鼻旁区和鼻底，更明显地改善畸形。同期行牙槽嵴裂自体髂骨游离移植，可减少手术次数、降低费用、获得理想效果，是矫治唇腭裂术后面中部继发畸形的一种有效方法。
文摘目的:采用多片段Le Fort I型截骨术矫治严重牙颌面畸形,并为克服术后骨段固位不良之缺点自制一种腭侧固定夹板。方法:以该手术方法联合双侧下颌升支矢状劈开术（BSSRO）矫治上颌宽度不足伴上下颌其它严重畸形的患者19例。采用单纯多片段Le FortI型截骨6例,联合BSSRO13例。19例中上颌两片段Le FortI型截骨12例,3片段7例。结果:术后随访16例,平均22.6m,66间距离平均扩宽7.3mm,33间平均扩宽3.9mm。无严重并发症及明显复发,咬合关系满意。结论:应用良好的腭侧固定夹板,采用多片段 Le FortI截骨联合BSSRO可一次满意矫治严重双颌畸形。
文摘目的本研究通过主观及客观性评估方法,对上颌骨Le Fort Ⅰ型截骨上颌骨向不同方向移动后鼻腔通气功能的变化进行评估。方法将30例需要接受正颌手术治疗的患者分为2组,前移组1 3例,采用上颌骨Le Fort I型截骨前移术;非前移组:1 7例,采用上颌骨Le Fort Ⅰ型截骨上抬、后退或下降术。术前、术后3个月及术后6个月分别对研究对象进行前鼻镜及鼻声反射检查。所有研究对象术前及术后6个月均完成NOSE量表的主观性评估,采用SPSS对术前及术后的结果进行统计学分析。结果鼻声反射检测结果显示两组患者的鼻腔阻力、鼻腔容积及鼻腔最小截面积3项指标在术后3个月及6个月时均较术前有所改善,但是前后差异没有统计学意义。NOSE量表的主观性评估结果显示,两研究组于术后6个月时的评估分值即主观症状改善较术前下降,然而仅非前移组术前术后差异有统计学意义。结论上颌骨Le Fort Ⅰ型单块截骨上颌骨向不同方向移动无论从客观上还是主观上都不会对患者的鼻腔通气功能产生不良影响。同时利用客观性(鼻声反射)及主观性(NOSE量表)检测手段可以有效地对鼻腔结构及功能进行评估。
